Skip to content
★ Sign in to follow
VM

Vincent Metzler

Wilson Therapeutics AB
Total declarations
5
Company
1
▲ Purchases (4 ops.)
€120.1M
▼ Sales (1 ops.)
€226k

Latest filing published 25 May 2018 for Wilson Therapeutics AB, €226k.

Filing timeline

BuySale
Vincent Metzler

Insider track record

Disclosed buys
4
Disclosed sells
1
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Vincent Metzler: trading record in brief

Vincent Metzler appears in our data through filings on Wilson Therapeutics AB shares, published by Finansinspektionen. The record holds 5 filings, for trades running from 5 September 2016 to 25 May 2018.

On the open market, the record shows 4 purchases worth €120.1M and 1 sale worth €226k. Netting one side against the other leaves €119.9M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2018, the count stands at no purchases and 1 sale.

The median purchase comes to €30k.

The record was last updated on 25 May 2018 with an open-market sale (€226k) in Wilson Therapeutics AB. The latest purchase dates back some time: it was published 3,715 days ago, on 6 September 2016. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Vincent Metzler

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▼
    Vice PresidentExecutivesWilson Therapeutics AB
    2M SEK26FI-SE
    10,000 shares@ SEK 232.000.2% of flowISIN SE0008293674FI:csv-fa39f5ac3f5727c9fc31
  • ▲
    Vice PresidentExecutivesWilson Therapeutics AB
    311,080 SEK26FI-SE
    5,555 shares@ SEK 56.000.0% of flowISIN SE0008293674FI:csv-fa59f359eba841397d4e
    Canonical exit: 5 Dec 2016 (T+90)
  • ▲
    Vice PresidentExecutivesWilson Therapeutics AB
    248,920 SEK26FI-SE
    4,445 shares@ SEK 56.000.0% of flowISIN SE0008293674FI:csv-d74d34ed445bd54e2192
    Canonical exit: 4 Dec 2016 (T+90)
  • ▲
    Vice PresidentExecutivesWilson Therapeutics AB
    1B SEK0FI-SE
    4,445 shares@ SEK 257,810.00ISIN SE0008293674FI:csv-1a8c52edbf300f1a4d8c
    Canonical exit: 4 Dec 2016 (T+90)
  • ▲
    Vice PresidentExecutivesWilson Therapeutics AB
    257,810 SEK0FI-SE
    4,445 shares@ SEK 58.0099.8% of flowISIN SE0008293674FI:csv-e3b8445c9390a01ce9f4
    Canonical exit: 4 Dec 2016 (T+90)

5 of 5 declarations